MYRIAD GENETICS ($MYGN) posted quarterly earnings results for Q2 2026 on Thursday, July 30th. The company reported earnings of -$0.25 per share, missing estimates of -$0.06 by $0.19. The company also reported revenue of $190,700,000, missing estimates of $210,149,916 by $-19,449,916.
Stock price change since market close: -29.03%
You can see Quiver Quantitative's $MYGN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MYRIAD GENETICS Insider Trading Activity
MYRIAD GENETICS insiders have traded $MYGN stock on the open market 6 times in the past 6 months. Of those trades, 5 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MYGN stock by insiders over the last 6 months:
- S. LOUISE PHANSTIEL has made 3 purchases buying 104,507 shares for an estimated $494,722 and 0 sales.
- SAMRAAT S. RAHA (President and CEO) purchased 40,000 shares for an estimated $199,844
- RASHMI KUMAR sold 15,000 shares for an estimated $66,843
- PAUL BISARO purchased 7,500 shares for an estimated $27,637
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
MYRIAD GENETICS Hedge Fund Activity
We have seen 98 institutional investors add shares of MYRIAD GENETICS stock to their portfolio, and 106 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 6,414,206 shares (-41.9%) from their portfolio in Q1 2026, for an estimated $28,863,927
- STATE STREET CORP removed 1,542,540 shares (-25.9%) from their portfolio in Q1 2026, for an estimated $6,941,430
- ACADIAN ASSET MANAGEMENT LLC added 1,322,441 shares (+134.1%) to their portfolio in Q1 2026, for an estimated $5,950,984
- HRT FINANCIAL LP added 1,317,451 shares (+281.0%) to their portfolio in Q1 2026, for an estimated $5,928,529
- JANE STREET GROUP, LLC added 1,148,114 shares (+2109.8%) to their portfolio in Q1 2026, for an estimated $5,166,513
- MARSHALL WACE, LLP added 1,081,456 shares (+4849.1%) to their portfolio in Q1 2026, for an estimated $4,866,552
- GLENVIEW CAPITAL MANAGEMENT, LLC added 824,571 shares (+18.0%) to their portfolio in Q1 2026, for an estimated $3,710,569
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
MYRIAD GENETICS Price Targets
Multiple analysts have issued price targets for $MYGN recently. We have seen 3 analysts offer price targets for $MYGN in the last 6 months, with a median target of $6.0.
Here are some recent targets:
- Brandon Couillard from Wells Fargo set a target price of $5.5 on 05/06/2026
- Kyle Boucher from TD Cowen set a target price of $6.0 on 05/06/2026
- Lu Li from UBS set a target price of $6.0 on 02/24/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
